Roche Holding Ltd - Net Worth and Insider Trading
Roche Holding Ltd Net Worth
The estimated net worth of Roche Holding Ltd is at least $195 Million dollars as of 2024-05-15. Roche Holding Ltd is the 10% Owner of Pandion Therapeutics Inc and owns about 3,086,084 shares of Pandion Therapeutics Inc (PAND) stock worth over $185 Million. Roche Holding Ltd is the 10% Owner of Jasper Therapeutics Inc and owns about 454,961 shares of Jasper Therapeutics Inc (JSPR) stock worth over $10 Million. Roche Holding Ltd is also the 10% Owner of Aileron Therapeutics Inc and owns about 35,118 shares of Aileron Therapeutics Inc (ALRN) stock worth over $136,960. Details can be seen in Roche Holding Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roche Holding Ltd has not made any transactions after 2023-01-25 and currently still holds the listed stock(s).
Transaction Summary of Roche Holding Ltd
Roche Holding Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roche Holding Ltd owns 9 companies in total, including Pandion Therapeutics Inc (PAND) , Spark Therapeutics Inc (ONCE) , and Foundation Medicine Inc (FMI) among others .
Click here to see the complete history of Roche Holding Ltd’s form 4 insider trades.
Insider Ownership Summary of Roche Holding Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 10 percent owner |
| ONCE | Spark Therapeutics Inc | 2019-12-17 | 10 percent owner |
| FMI | Foundation Medicine Inc | 2018-07-31 | director & 10 percent owner & other: See footnote (1) |
 | | 2018-07-18 | 10 percent owner |
| | 2017-07-05 | 10 percent owner |
| | 2016-03-17 | 10 percent owner |
| | 2021-10-28 | 10 percent owner |
| | 2023-01-25 | 10 percent owner |
| | 2023-10-25 | 10 percent owner |
Roche Holding Ltd Latest Holdings Summary
Roche Holding Ltd currently owns a total of 3 stocks. Among these stocks, Roche Holding Ltd owns 3,086,084 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $185 Million and a weighting of 95.05%. Roche Holding Ltd owns 454,961 shares of Jasper Therapeutics Inc (JSPR) as of January 25, 2023, with a value of $10 Million and a weighting of 4.88%. Roche Holding Ltd also owns 35,118 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $136,960 and a weighting of 0.07%.
Latest Holdings of Roche Holding Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 3,086,084 | 60.05 | 185,319,344 |
| JSPR | Jasper Therapeutics Inc | 2023-01-25 | 454,961 | 20.92 | 9,517,784 |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 35,118 | 3.90 | 136,960 |
Holding Weightings of Roche Holding Ltd
Roche Holding Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Roche Holding Ltd has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 36,111 shares on July 21, 2020, which cost Roche Holding Ltd around $649,998.
According to the SEC Form 4 filings, Roche Holding Ltd has made a total of 1 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Jasper Therapeutics Inc is the sale of 7,500 shares on January 25, 2023, which brought Roche Holding Ltd around $141,750.
According to the SEC Form 4 filings, Roche Holding Ltd has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 5,970 shares on July 5, 2017, which cost Roche Holding Ltd around $2 Million.
Insider Trading History of Roche Holding Ltd
- 1
Roche Holding Ltd Trading Performance
GuruFocus tracks the stock performance after each of Roche Holding Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roche Holding Ltd is -10.18%. GuruFocus also compares Roche Holding Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roche Holding Ltd within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Roche Holding Ltd's insider trading performs compared to the benchmark.
Performance of Roche Holding Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.22 | | | | | |
| Relative Return to S&P 500(%) | -3.28 | | | | | |
Roche Holding Ltd Ownership Network
Roche Holding Ltd Owned Company Details
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Roche Holding Ltd is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
Roche Holding Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Roche Holding Ltd. You might contact Roche Holding Ltd via mailing address: Roche Holding, Ltd., Grenzacherstrasse 124, Basel V8 Ch-4070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
